Skip to main content

Advertisement

Table 2 Operative variables and postoperative outcomes of the enrolled patients upon undergoing radical hepatectomy

From: Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

Characteristic Hepatectomy-TACE group (n = 116) Hepatectomy alone group (n = 118) P-value
Cirrhosis [cases (%)]
 Present 50 (43.1) 42 (35.6) 0.285
 Absent 66 (56.9) 76 (64.4)
Tumor size [cases (%)]
 5–10 cm 82 (70.7) 97 (82.2) 0.055
 > 10 cm 34 (29.3) 21 (17.8)
Operation time (min) 173.2 ± 48.6 182.3 ± 65.2 0.225
Operation blood loss (mL) 518.9 ± 441.6 421.6 ± 353.3 0.064
Blood transfusion [cases (%)] 26 (22.4) 18 (15.3) 0.183
Extent of liver resection [cases (%)]
 Major 45 (38.8) 46 (39.0) 1.000
 Minor 71 (61.2) 72 (61.0)
Resection margin [cases (%)]
 < 2 cm 91 (78.4) 92 (78.0) 1.000
 ≥ 2 cm 25 (21.6) 26 (22.0)
Postoperative complications [cases (%)] 24 (20.7) 23 (19.5) 0.871
 Grade 1
  Fever 5 (4.3) 3 (2.5) 0.497
 Grade 2
  Fever 2 (1.7) 1 (0.8) 0.620
  Ascites 5 (4.3) 3 (2.5) 0.497
  Transient jaundice 5 (4.3) 6 (5.1) 1.000
  Pleural effusion 3 (2.6) 3 (2.5) 1.000
  Hypoalbuminemia 3 (2.6) 5 (4.2) 0.722
 Grade 3
  Liver bleeding 1 (0.9) 2 (1.7) 1.000
  1. Continuous variables are compared by Student t-test; categorical variables are compared by the χ2 test or the Fisher’s exact test
  2. Hepatectomy-TACE: radical hepatectomy followed by adjuvant transcatheter arterial chemoembolization; Hepatectomy Alone: had undergone only radical hepatectomy